Status:
COMPLETED
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
Lead Sponsor:
Unity Health Toronto
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Dyspnea
Acute Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate a validated diagnostic prediction model in the appropriate diagnosis of Acute Heart Failure (AHF) in patients presenting at the emergency department with undif...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Presentation to the ED with undifferentiated shortness of breath
Exclusion
- Dyspnea of obvious cause, e.g. chest trauma, obvious clinical exacerbation of known chronic obstructive disease
- Obvious pulmonary edema in a patient with a known diagnosis of HF and recently admitted to hospital for HF
- Clinician does not plan to treat for AHF at all, but rather to pursue other causes of dyspnea (i.e., probability of AHF ≤ 20%)
- Clinician plans to treat for AHF and not to pursue other causes of dyspnea (i.e., probability of AHF ≥ 80%)
- Acute coronary syndrome within one month
- Chronic renal failure (serum creatinine ≥ 250 mol/l)
- Anticipated life expectancy \< 6 months due to non-cardiovascular causes
- Participation in another interventional outcome trial
- Inability to obtain informed consent, including inability of patient to understand English
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT01193998
Start Date
September 1 2010
End Date
June 1 2014
Last Update
June 16 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Wayne State University
Detroit, Michigan, United States, 48201
2
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8
3
Waikato Hospital Cardiology Clinical Trials Unit
Waikato, New Zealand